Coronavirus vaccine update: Pfizer-BioNTech’s 8-month journey of developing Covid-19 vaccine
Pfizer-BioNTech started the Phase 3 clinical trial of BNT162b2 on July 27. (Reuters image) Coronavirus Pfizer-BioNTech vaccine update: In the much-awaited announcement, Pfizer has unveiled Phase 3 human trial final efficacy analysis of BNT162b2 Covid-19 vaccine. It has said the mRNA-based Coronavirus vaccine, jointly developed by US drugmaker Pfizer and German pharma giant BioNTech, has … Read more